Remedy Meds

Remedy Meds’ pricing is the headline feature. The clinic publishes $299 per month for compounded semaglutide and $399 per month for compounded tirzepatide, often with first‑month discounts on select landing pages. The price is described as the same at all doses, a meaningful advantage during titration when many programs hike monthly fees. Medication, clinician visits, and lab work are included in the subscription, and the help center is explicit that there are no additional shipping costs. For patients comparing FDA‑approved brands, a cash‑pay Ozempic option is shown, though most users choose compounded pricing for affordability. We reserve a few points because the Terms allow shipping and handling to be added to invoices and because compounding availability can change under regulatory pressure. Still, in cash‑pay GLP‑1 care, this is among the clearest price stacks.

Clinically, Remedy Meds routes care through independent medical groups, including OpenLoop’s multi‑state network, with a formal telehealth consent and required labs before and during treatment. The site emphasizes U.S. partner pharmacies and safety pages for compounded GLP‑1s. Those are positives. Offsetting factors are significant. Compounded semaglutide and tirzepatide are not FDA‑approved products, and on September 9, 2025, FDA cited Remedy Meds for false or misleading compounded GLP‑1 claims. While the company also highlights brand availability in places, its core model leans on compounded medications. Public reputation signals are split: 4.6 on Trustpilot with active responses, but C‑ with the BBB alongside complaint volume. On balance, we credit the clinician‑plus‑labs framework and transparency, but subtract for regulatory exposure and the inherent variability of compounded meds.

Starting care is quick. You complete intake, book a video visit, and receive required labs via national partners Quest, Labcorp, and BioReference, with the option to upload recent results instead. The portal supports scheduling, refills, and shipment tracking, and the team advertises unlimited telehealth access seven days a week, plus a published phone line staffed 8 am to 8 pm Eastern daily. The process is clearly explained in “Getting Started” materials and the help center. We withhold two points because onboarding speed ultimately hinges on pharmacy capacity and lab turnaround, and because compounding policy shifts can change the starter flow. Overall, it is one of the most straightforward GLP‑1 onboardings available right now.

Remedy Meds is focused by design. Within weight care, it offers compounded semaglutide and tirzepatide as injectables and as oral disintegrating tablets, giving an alternative for needle‑averse patients. Pages clarify that GLP‑1s are fulfilled by U.S. pharmacies and that compounded formulations are not FDA‑approved. Select landing pages list a cash‑pay Ozempic path for those who prefer a brand, subject to clinician judgment and availability. Outside obesity medicine, Remedy does not market sexual health, dermatology, hair loss, or hormone programs. The clinic’s depth inside GLP‑1 therapy is strong, and oral options broaden access, but breadth across other telehealth lines is intentionally limited.

Logistics are well‑documented. The help center notes no shipping fees, email tracking, and delivery within seven business days, with no Friday to Sunday shipments for safety. Articles describe cold‑pack use to protect temperature‑sensitive medications. The portal shows shipment tracking and scheduled refills, which helps avoid dose gaps. We deduct points for two reasons. First, Remedy’s Terms still reserve the right to add shipping and handling, which conflicts with marketing copy. Second, as with all cold‑chain therapy, delays can occur due to carriers or pharmacy capacity, and public complaint boards reflect mixed fulfillment experiences common to the category. Overall, shipping is cost‑inclusive and predictable, but not flawless.

Support channels are easy to find: a staffed phone line 8 am to 8 pm Eastern every day, plus dedicated emails for billing, medication, order status, and appointments. The company publishes a practical help center and quick‑start guides. Trustpilot data suggest rapid replies to negatives and a high overall satisfaction rate. Balancing that, the BBB profile shows a C‑ rating with dozens of complaints, and the refund policy is firm once a month’s prescription is processed at the pharmacy. We grade slightly above average for transparency and multiple contact paths, with points held back for complaint volume and the strict refund line after processing.

The site is clean, mobile‑friendly, and organized around the GLP‑1 journey. Pricing is visible, the “find your medication” section shows costs plainly, and the portal aggregates labs, appointments, and shipment tracking. The combination of dose‑agnostic pricing and a single dashboard reduces cognitive load for long‑term treatment. Minor quibbles keep it short of perfect: some drug and price tiles appear only on promo pages, and we did not find a single, universal shipping SLA on the marketing pages. Functionally, though, Remedy’s UX is among the smoother GLP‑1 flows right now.